Skip to main content

Table 2 Factor H binding protein (fHbp) peptide types in invasive Neisseria meningitidis from Québec, Canada, 2009-2013

From: Characterization of invasive Neisseria meningitidis strains from Québec, Canada, during a period of increased serogroup B disease, 2009-2013: phenotyping and genotyping with special emphasis on the non-carbohydrate protein vaccine targets

Novartis variant 1 Peptides # of isolates (serogroup)
(Pfizer subfamily B) 1.1 2 (B, two ST-32 cc)
  1.4 5 (B, four ST-41/44 cc, one ST-35 cc)
  1.12 2 (B, one UAa; C, one ST-11 cc)
  1.13 5 (B, one ST-60 cc, one ST-254 cc, two ST-1157 cc, one UA)
  1.14 1 (B, ST-41/44 cc)
  1.15 152 (B, 152 ST-269 cc)
  1.100 1 (B, ST-41/44 cc)
  1.110 1 (B, UA)
  1.129 1 (C, ST-11 cc)
  1.144 1 (B, ST-32 cc)
  1.218 1 (C, ST-11 cc)
  1.249 1 (B, ST-269 cc)
  1.278 1 (Y, ST-167 cc)
  1.410 4 (B, four ST-41/44 cc)
  1.687 1 (B, ST-41/44 cc)
Novartis variant 2 2.16 15 (3B, three ST-35 cc; 1C, ST-11 cc; 2Y, one ST-22 cc; one UA; 9W, nine ST-22 cc)
(Pfizer subfamily A)   
  2.19 32 (31B, five ST-269 cc; 26 ST-41/44 cc; 1×, one ST-32 cc)
  2.21 1 (Y, ST-174 cc)
  2.22 1 (B, ST-32 cc)
  2.23 6 (3B, two ST-41/44 CC; one ST-37 cc; 3Y, one ST-167 cc; two UA)
  2.24 5 (4B, two ST-41/44 cc, two UA; 1Y, ST-167 cc)
  2.25 9 (1B, ST-103 cc; 7Y, six ST-23 cc; one ST-167 cc; 1 W, ST-22 cc)
  2.102 2 (1B, ST-213 cc; 1C, ST-11 cc)
  2.106 1 (B, UA)
  2.527 1 (B, UA)
  2.629 1 (Y, UA)
  2.632 1 (B, ST-41/44 cc)
Novartis variant 3 3.30 2 (B, ST-41/44 cc, ST-32 cc)
(Pfizer subfamily A) 3.47 2 (B, two ST-461 cc)
  3.555 1 (B, UA)
No peptide allele 669 2 (C, two ST-11 cc)
  allele 755 1 (B, ST-269 cc)
Recombination disrupted gene 1 (B, UA)
  1. aUA = not assigned to any known clonal complex by pubmlst.org/neisseria